세계 임상시험 용품 시장 규모는 2034년까지 8.8%의 CAGR로 성장할 것으로 예상됩니다.
신흥 시장 성장 기회로 산업 성장 촉진:
임상시험은 중국, 인도, 일본 등 아시아태평양으로 이동하고 있으며, 특히 중국, 한국, 인도 등의 국가에서는 선진국에 비해 비용이 저렴해 환자 모집이 크게 증가하고 있습니다. 개발도상국에서의 초기 단계 임상시험은 비용이 현저하게 저렴해 제약사들에게 매력적인 선택이 되고 있습니다. 예를 들어, 2023년 11월 아스트라제네카는 경쟁이 치열한 KRAS G12D 분야에서 입지를 확보하기 위해 중국 생명공학 기업과 파트너십을 체결하고 계약금으로 2,400만 달러를 지불했습니다. 이번 계약으로 아스트라제네카는 유시노바가 전임상 개발 중인 암 유전자 표적 저분자 억제제 UA022에 대한 전 세계 라이선스를 획득했습니다. 중국 생명공학 기업 우시 앱텍(WuXi AppTec)과 같은 파트너와 협력하여 이 분자의 발견과 개발을 주도적으로 진행했고, 결국 총 3억 9,500만 달러의 마일스톤 지급 가능성을 포함한 아스트라제네카의 제안이 매우 매력적이라고 판단하고 이를 수락하기로 결정했습니다. 또한, Novartis는 2023년 11월 한국의 생명공학 기업 종근당제약과 초기 단계의 HDAC6 억제제에 대한 계약을 체결한 바 있습니다. 계약 조건에 따라 노바티스는 8,000만 달러의 계약금을 지급하고 약 12억 3,000만 달러에 달하는 추가 개발 및 규제 마일스톤을 지급하기로 약속했습니다. 이러한 추세는 임상시험 운영 비용이 낮은 국가로의 전략적 이동을 반영합니다.
세계 임상시험 용품 시장을 조사했으며, 시장 개요, 시장 성장에 영향을 미치는 요인과 시장 기회 분석, 시장 규모 추정 및 예측, 각 부문별·지역별 상세 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 보고서 개요
제2장 주요 요약
제3장 시장 개요
주요 조사 결과
시장 역학
시장 성장 촉진요인
시장 성장 억제요인
시장 기회
COVID-19의 영향 분석
Porter's Five Forces 분석
PEST 분석
제4장 임상시험 용품 시장 분석 : 로케이션별
주요 조사 결과
시장 매력도 지수
시장 규모 추정과 예측
해외 임상 사이트
국내 임상 사이트
시장 규모 추정과 예측 : 지역별
시장 점유율 : 지역별
제5장 임상시험 용품 시장 분석 : 유형별
주요 조사 결과
시장 매력도 지수
시장 규모 추정과 예측
저분자 제품
바이오로직스
의료기기
시장 규모 추정과 예측 : 지역별
시장 점유율 : 지역별
제6장 임상시험 용품 시장 분석 : 서비스별
주요 조사 결과
시장 매력도 지수
시장 규모 추정과 예측
제조
시장 규모 추정과 예측 : 지역별
시장 점유율 : 지역별
어세이·테스트 키트
IMP·IND
플라세보
기타
포장·라벨링
시장 규모 추정과 예측 : 지역별
시장 점유율 : 지역별
물류·유통
시장 규모 추정과 예측 : 지역별
시장 점유율 : 지역별
콜드체인 유통
비콜드체인 유통
보관·보유
시장 규모 추정과 예측 : 지역별
시장 점유율 : 지역별
콤퍼레이터 조달
시장 규모 추정과 예측 : 지역별
시장 점유율 : 지역별
기타
시장 규모 추정과 예측 : 지역별
시장 점유율 : 지역별
제7장 임상시험 용품 시장 분석 : 치료 분야별
주요 조사 결과
시장 매력도 지수
시장 규모 추정과 예측
종양
중추신경계·정신장애
심혈관질환(CVD)
감염증
면역질환
혈액질환
대사장애
소화기질환
기타
시장 규모 추정과 예측 : 지역별
시장 점유율 : 지역별
제8장 임상시험 용품 시장 분석 : 단계별
주요 조사 결과
시장 매력도 지수
시장 규모 추정과 예측
단계 I
단계 II
단계 III
단계 IV
시장 규모 추정과 예측 : 지역별
시장 점유율 : 지역별
제9장 임상시험 용품 시장 분석 : 최종사용자별
주요 조사 결과
시장 매력도 지수
시장 규모 추정과 예측
제약·바이오테크놀러지 기업
CRO
의료기기 기업
기타
시장 규모 추정과 예측 : 지역별
시장 점유율 : 지역별
제10장 임상시험 용품 시장 분석 : 지역별
주요 조사 결과
시장 규모 추정과 예측
제11장 북미의 임상시험 용품 시장 분석
제12장 유럽의 임상시험 용품 시장 분석
제13장 아시아의 임상시험 용품 시장 분석
제14장 라틴아메리카의 임상시험 용품 시장 분석
제15장 중동 및 아프리카의 임상시험 용품 시장 분석
제16장 기업 개요
경쟁 상황
전략적 전망
Thermo Fisher Scientific Inc.
Catalent Inc.
IQVIA Holdings Inc
Marken
Eurofins Scientific SE
ICON Plc
Parexel International
Lonza Group AG
Biocair
KLIFO
Walden Group SAS
PCI Pharma Services
Sharp Services, LLC
Bionical Limited
제17장 결론과 제안
Visiongain에 의한 결론
진출 기업에 대한 추천사항
ksm
영문 목차
영문목차
The global Clinical Trial Supplies market is projected to grow at a CAGR of 8.8% by 2034
The Clinical Trial Supplies Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Opportunities in Emerging Markets Projected to Boost Industry Growth
Clinical trials are increasingly moving to developing economies like China, India, and Japan in the Asia Pacific region, with significant growth in patient recruitment in countries such as China, South Korea, and India due to lower costs compared to developed nations. Early phase clinical trials in developing nations are notably cheaper, making them an attractive option for pharmaceutical companies. For instance, in November 2023, AstraZeneca forged a partnership with a Chinese biotechnology company to secure a position in the competitive KRAS G12D field, exchanging $24 million upfront. The agreement grants AstraZeneca a worldwide license to UA022, a small molecule inhibitor targeting the historically challenging oncogene, which was undergoing preclinical development at Usynova. The Chinese biotech, in collaboration with partners such as WuXi AppTec, spearheaded the discovery and advancement of the molecule, ultimately determining that AstraZeneca's offer, which includes potential milestone payments totalling up to $395 million, was highly compelling and thus opted to accept it. Also, in November 2023, Novartis entered into an agreement with Chong Kun Dang Pharmaceutical, a biotechnology company based in Korea, for an early-stage HDAC6 Inhibitor. As per the contract terms, Novartis will provide an initial payment of $80 million and commit to additional development and regulatory milestone payments amounting to nearly $1.23 billion. These trends reflect a strategic shift towards countries offering lower operational expenses for clinical trials.
Challenges Posed by Lack of Comparator Sourcing
The clinical trial supplies market faces significant hurdles due to restrictions imposed by pharmaceutical manufacturers on procuring their products as comparators for clinical trials. These limitations typically encompass quantity constraints, prolonged approval procedures, and additional disclosure requirements, posing challenges for researchers and clinical trial supply chain management. Biologics, in particular, accentuate these difficulties as the lack of internal protocols and procedures from manufacturers exacerbates the situation. For instance, Sharp Clinical Services specializes in offering solutions for clinical trial supply chains, with a focus on comparator sourcing and supply. They cater to pharmaceutical companies conducting clinical trials, aiming to streamline the procurement process. Such firms play a pivotal role in addressing the challenges linked to comparator sourcing, thereby enhancing the efficiency of the clinical trial supply chain. Pharmaceutical manufacturers often impose strict quantity limits on procuring their products for use as comparators in clinical trials. Additionally, obtaining approval for these products can be time-consuming.
What Questions Should You Ask before Buying a Market Research Report?
How is the clinical trial supplies market evolving?
What is driving and restraining the clinical trial supplies market?
How will each clinical trial supplies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
How will the market shares for each clinical trial supplies submarket develop from 2024 to 2034?
What will be the main driver for the overall market from 2024 to 2034?
Will leading clinical trial supplies markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
Who are the leading players and what are their prospects over the forecast period?
What are the clinical trial supplies projects for these leading companies?
How will the industry evolve during the period between 2024 and 2034? What are the implications of clinical trial supplies projects taking place now and over the next 10 years?
Is there a greater need for product commercialisation to further scale the clinical trial supplies market?
Where is the clinical trial supplies market heading and how can you ensure you are at the forefront of the market?
What are the best investment options for new product and service lines?
What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the clinical trial supplies market today, and over the next 10 years:
Our 373-page report provides 155 tables and 243 charts/graphs exclusively to you.
The report highlights key lucrative areas in the industry so you can target them - NOW.
It contains in-depth analysis of global, regional and national sales and growth.
It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the clinical trial supplies market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2034 and other analyses reveal commercial prospects
In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
You will find original analyses, with business outlooks and developments.
Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising clinical trial supplies prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.
Segments Covered in the Report
Location
Offshore Clinical Site
Domestic Clinical Site
Type
Small Molecule Products
Biologic Products
Medical Devices
Services
Manufacturing
Assays and Test Kits
IMPs and INDs
Placebos
Others
Packaging and Labelling
Logistics & Distribution
Cold Chain Distribution
Non-cold Chain Distribution
Storage & Retention
Comparator Sourcing
Other CTS Services
Therapeutic Areas
Oncology
CNS and Mental Disorders
Cardiovascular Disease (CVD)
Infectious Disease
Immunology Disease
Blood Disorders
Metabolic Disorders
Digestive Disorders
Other Therapeutic Areas
Phase
Phase I
Phase II
Phase III
Phase IV
End-users
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
Medical Device Companies
Other End-users
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:
North America
U.S.
Canada
Europe
Germany
UK
France
Spain
Italy
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
MEA
GCC
South Africa
Rest of MEA
The report also includes profiles and for some of the leading companies in the Clinical Trial Supplies Market, 2024 to 2034, with a focus on this segment of these companies' operations.
Leading companies profiled in the report
Biocair
Bionical Limited
Catalent Inc.
Eurofins Scientific SE
ICON plc
IQVIA Holdings Inc.
KLIFO
Lonza Group AG
Marken
Parexel International
PCI Pharma Services
Sharp Services, LLC
Thermo Fisher Scientific Inc.
Walden Group SAS
Overall world revenue for Clinical Trial Supplies Market, 2024 to 2034 in terms of value the market will surpass US$4,100.0 million in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Clinical Trial Supplies Market, 2024 to 2034 report help you?
In summary, our 370+ page report provides you with the following knowledge:
Revenue forecasts to 2034 for Clinical Trial Supplies Market, 2024 to 2034, with forecasts for location, type, services, therapeutic areas, phase, and end-users, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
Revenue forecasts to 2034 for five regional and 22 key national markets - See forecasts for the Clinical Trial Supplies Market, 2024 to 2034 market in North America, Europe, Asia Pacific, Latin America, and MEA. Also includes forecast for the market in the U.S., Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
Prospects for established firms and those seeking to enter the market - including company profiles for 14 of the major companies involved in the Clinical Trial Supplies Market, 2024 to 2034.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Clinical Trial Supplies Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.
Table of Contents
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Clinical Trial Supplies Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Growing Decentralisation of Clinical Trials
3.2.1.2 Increasing Number of Clinical Trials
3.2.1.3 Rising Demand for Biologics Propelling Growth of Cold Chain Distribution Supplies
3.2.1.4 Integration of Technical Solutions
3.2.1.5 Increasing Investments in the Development of Novel Pharmaceuticals
3.2.1.6 Technology Advancements are Propelling Market Expansion
3.2.2 Market Restraining Factors
3.2.2.1 Unavailability of Storage Facilities
3.2.2.2 Lack of Comparator Sourcing
3.2.2.3 High Costs Associated with Drug Developments
3.2.3 Market Opportunities
3.2.3.1 Emerging Economies Expansion and Prioritisation of R&D
3.2.3.2 Increasing Opportunities for Emerging Markets
3.2.3.3 Reduction in Clinical Trials Cost by using Supply Chain is Expected to Propel Market Growth
3.2.3.4 Collaboration and Partnerships among Clinical Trial Supplies Companies
3.3 COVID-19 Impact Analysis
3.4 Porter's Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat of Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Clinical Trial Supplies Market Analysis by Location
4.1 Key Findings
4.2 Location Segment: Market Attractiveness Index
4.3 Clinical Trial Supplies Market Size Estimation and Forecast by Location
4.4 Offshore Clinical Site
4.4.1 Market Size by Region, 2024-2034 (US$ Million)
4.4.2 Market Share by Region, 2024 & 2034 (%)
4.5 Domestic Clinical Site
4.5.1 Market Size by Region, 2024-2034 (US$ Million)
4.5.2 Market Share by Region, 2024 & 2034 (%)
5 Clinical Trial Supplies Market Analysis by Type
5.1 Key Findings
5.2 Type Segment: Market Attractiveness Index
5.3 Clinical Trial Supplies Market Size Estimation and Forecast by Type
5.4 Small Molecule Products
5.4.1 Market Size by Region, 2024-2034 (US$ Million)
5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5 Biologic Products
5.5.1 Market Size by Region, 2024-2034 (US$ Million)
5.5.2 Market Share by Region, 2024 & 2034 (%)
5.6 Medical Devices
5.6.1 Market Size by Region, 2024-2034 (US$ Million)
5.6.2 Market Share by Region, 2024 & 2034 (%)
6 Clinical Trial Supplies Market Analysis by Services
6.1 Key Findings
6.2 Services Segment: Market Attractiveness Index
6.3 Clinical Trial Supplies Market Size Estimation and Forecast by Services
6.4 Manufacturing
6.4.1 Market Size by Region, 2024-2034 (US$ Million)
6.4.2 Market Share by Region, 2024 & 2034 (%)
6.4.3 Assays and Test kits
6.4.3.1 Market Size by Region, 2024-2034 (US$ Million)
6.4.3.2 Market Share by Region, 2024 & 2034 (%)
6.4.4 IMPs and INDs
6.4.4.1 Market Size by Region, 2024-2034 (US$ Million)
6.4.4.2 Market Share by Region, 2024 & 2034 (%)
6.4.5 Placebos
6.4.5.1 Market Size by Region, 2024-2034 (US$ Million)
6.4.5.2 Market Share by Region, 2024 & 2034 (%)
6.4.6 Others
6.4.6.1 Market Size by Region, 2024-2034 (US$ Million)
6.4.6.2 Market Share by Region, 2024 & 2034 (%)
6.5 Packaging and Labelling
6.5.1 Market Size by Region, 2024-2034 (US$ Million)
6.5.2 Market Share by Region, 2024 & 2034 (%)
6.6 Logistics & Distribution
6.6.1 Market Size by Region, 2024-2034 (US$ Million)
6.6.2 Market Share by Region, 2024 & 2034 (%)
6.6.3 Cold Chain Distribution
6.6.3.1 Market Size by Region, 2024-2034 (US$ Million)
6.6.3.2 Market Share by Region, 2024 & 2034 (%)
6.6.4 Non-cold Chain Distribution
6.6.4.1 Market Size by Region, 2024-2034 (US$ Million)
6.6.4.2 Market Share by Region, 2024 & 2034 (%)
6.7 Storage & Retention
6.7.1 Market Size by Region, 2024-2034 (US$ Million)
6.7.2 Market Share by Region, 2024 & 2034 (%)
6.8 Comparator Sourcing
6.8.1 Market Size by Region, 2024-2034 (US$ Million)
6.8.2 Market Share by Region, 2024 & 2034 (%)
6.9 Other CTS Services
6.9.1 Market Size by Region, 2024-2034 (US$ Million)
6.9.2 Market Share by Region, 2024 & 2034 (%)
7 Clinical Trial Supplies Market Analysis by Therapeutic Areas
7.1 Key Findings
7.2 Therapeutic Areas Segment: Market Attractiveness Index
7.3 Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
7.4 Oncology
7.4.1 Market Size by Region, 2024-2034 (US$ Million)
7.4.2 Market Share by Region, 2024 & 2034 (%)
7.5 CNS and Mental Disorders
7.5.1 Market Size by Region, 2024-2034 (US$ Million)
7.5.2 Market Share by Region, 2024 & 2034 (%)
7.6 Cardiovascular Disease (CVD)
7.6.1 Market Size by Region, 2024-2034 (US$ Million)
7.6.2 Market Share by Region, 2024 & 2034 (%)
7.7 Infectious Disease
7.7.1 Market Size by Region, 2024-2034 (US$ Million)
7.7.2 Market Share by Region, 2024 & 2034 (%)
7.8 Immunology Disease
7.8.1 Market Size by Region, 2024-2034 (US$ Million)
7.8.2 Market Share by Region, 2024 & 2034 (%)
7.9 Blood Disorders
7.9.1 Market Size by Region, 2024-2034 (US$ Million)
7.9.2 Market Share by Region, 2024 & 2034 (%)
7.10 Metabolic Disorders
7.10.1 Market Size by Region, 2024-2034 (US$ Million)
7.10.2 Market Share by Region, 2024 & 2034 (%)
7.11 Digestive Disorders
7.11.1 Market Size by Region, 2024-2034 (US$ Million)
7.11.2 Market Share by Region, 2024 & 2034 (%)
7.12 Other Therapeutic Areas
7.12.1 Market Size by Region, 2024-2034 (US$ Million)
7.12.2 Market Share by Region, 2024 & 2034 (%)
8 Clinical Trial Supplies Market Analysis by Phase
8.1 Key Findings
8.2 Phases Segment: Market Attractiveness Index
8.3 Clinical Trial Supplies Market Size Estimation and Forecast by Phase
8.4 Phase I
8.4.1 Market Size by Region, 2024-2034 (US$ Million)
8.4.2 Market Share by Region, 2024 & 2034 (%)
8.5 Phase II
8.5.1 Market Size by Region, 2024-2034 (US$ Million)
8.5.2 Market Share by Region, 2024 & 2034 (%)
8.6 Phase III
8.6.1 Market Size by Region, 2024-2034 (US$ Million)
8.6.2 Market Share by Region, 2024 & 2034 (%)
8.7 Phase IV
8.7.1 Market Size by Region, 2024-2034 (US$ Million)
8.7.2 Market Share by Region, 2024 & 2034 (%)
9 Clinical Trial Supplies Market Analysis by End-users
9.1 Key Findings
9.2 End-users Segment: Market Attractiveness Index
9.3 Clinical Trial Supplies Market Size Estimation and Forecast by End-users
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Market Size by Region, 2024-2034 (US$ Million)
9.4.2 Market Share by Region, 2024 & 2034 (%)
9.5 Contract Research Organizations (CROs)
9.5.1 Market Size by Region, 2024-2034 (US$ Million)
9.5.2 Market Share by Region, 2024 & 2034 (%)
9.6 Medical Device Companies
9.6.1 Market Size by Region, 2024-2034 (US$ Million)
9.6.2 Market Share by Region, 2024 & 2034 (%)
9.7 Other End-users
9.7.1 Market Size by Region, 2024-2034 (US$ Million)
9.7.2 Market Share by Region, 2024 & 2034 (%)
10 Clinical Trial Supplies Market Analysis by Region
10.1 Key Findings
10.2 Regional Market Size Estimation and Forecast
11 North America Clinical Trial Supplies Market Analysis
11.1 Key Findings
11.2 North America Clinical Trial Supplies Market Attractiveness Index
11.3 North America Clinical Trial Supplies Market by Country, 2024, 2029 & 2034 (US$ Million)
11.4 North America Clinical Trial Supplies Market Size Estimation and Forecast by Country
11.5 North America Clinical Trial Supplies Market Size Estimation and Forecast by Location
11.6 North America Clinical Trial Supplies Market Size Estimation and Forecast by Type
11.7 North America Clinical Trial Supplies Market Size Estimation and Forecast by Services
11.7.1 North America Clinical Trial Supplies Market Size Estimation and Forecast by Manufacturing Services
11.7.2 North America Clinical Trial Supplies Market Size Estimation and Forecast by Logistics & Distribution Services
11.8 North America Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
11.9 North America Clinical Trial Supplies Market Size Estimation and Forecast by Phase
11.10 North America Clinical Trial Supplies Market Size Estimation and Forecast by End-users
11.11 U.S. Clinical Trial Supplies Market Analysis
